Latest news
Loading news…
Biofrontera
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Leverkusen, Nordrhein-Westfalen, Germany Founded 1997 51-100 employees For Profit
Biofrontera is a biopharmaceutical company specializing in treating dermatological conditions and diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Ticker
B8F
ETR - Deutsche Börse XETRA
Patents
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- B8F
- Exchange
- ETR - Deutsche Börse XETRA
- IPO date
- Oct 30, 2006
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 13
- Active products
- 12
- Patents granted
- 0
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $607K
Company Info
- Founded
- 1997
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 48
- HQ
- Leverkusen, Nordrhein-Westfalen, Germany
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Oct 30, 2006
Signals & Scores
- Heat score
- Medium
- Growth score
- High
- Trend (7d)
- 0.1
- Trend (30d)
- 0
- Trend (90d)
- 0
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Biofrontera
Loading news…
FAQs about Biofrontera
People who checked this page also checked these
Browse the full Acquirezy directory.